Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Milton L. Wainberg, MD

Articles by Milton L. Wainberg, MD

Recognizing the pandemic's impact on MSDs can help us increase funding, research, and implementation of MSD treatment.

Challenges and Opportunities Beyond COVID-19

ByMilton L. Wainberg, MD

December 22nd 2021

How can recognizing the pandemic's impact on MSDs help us increase funding, research, and implementation of MSD treatment?

Latest Updated Articles

Challenges and Opportunities Beyond COVID-19
Published: December 22nd 2021 | Updated:

Trending on Psychiatric Times

Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines

Fostering Resiliency in Mental Health Professionals: A Strengths-Based, Trauma-Informed Framework

The Importance of Guidelines

Turning Despair into Joy in Music, Psychiatry, and Society

© 2025 MJH Life Sciences^®

All rights reserved.